Alzheimer’s disease – Alzheimer’s disease is a progressive neurodegenerative disorder characterized by the gradual loss of memory and cognitive functions. It begins with mild memory lapses and confusion, eventually leading to severe memory impairment and disorientation. As the disease progresses, individuals may experience difficulty in speaking, swallowing, and walking. The brain undergoes significant changes, including the accumulation of amyloid plaques and tau tangles. These changes disrupt communication between neurons, leading to their eventual death. The progression of Alzheimer’s disease varies among individuals, but it generally worsens over time.
Progressive supranuclear palsy – Progressive supranuclear palsy is a rare brain disorder that affects movement, control of walking, balance, and eye movements. It is characterized by the gradual deterioration of specific areas of the brain, leading to symptoms such as stiffness, awkward movements, and difficulty with eye movements. As the disease advances, individuals may experience problems with speech and swallowing. The condition is associated with the accumulation of abnormal tau protein in the brain. This accumulation disrupts normal brain function and leads to the symptoms observed. The progression of symptoms can vary, but they typically worsen over time.
Frontotemporal dementia – Frontotemporal dementia is a group of disorders caused by progressive nerve cell loss in the brain’s frontal and temporal lobes. This leads to changes in personality, behavior, and language. Individuals may exhibit socially inappropriate behavior, apathy, or loss of empathy. As the disease progresses, language difficulties and motor problems may develop. The condition is associated with abnormal protein accumulations, including tau, in the brain. The progression of frontotemporal dementia varies, but symptoms generally worsen over time.
Corticobasal degeneration – Corticobasal degeneration is a rare neurodegenerative disorder that affects movement and cognitive functions. It is characterized by the progressive loss of nerve cells in specific areas of the brain, leading to symptoms such as muscle stiffness, tremors, and difficulty with coordination. As the disease progresses, individuals may experience cognitive decline and speech difficulties. The condition is associated with the accumulation of abnormal tau protein in the brain. This accumulation disrupts normal brain function and leads to the observed symptoms. The progression of corticobasal degeneration varies, but symptoms typically worsen over time.
Mild cognitive impairment – Mild cognitive impairment is a condition characterized by noticeable changes in cognitive abilities, such as memory and thinking skills, that are greater than expected for a person’s age. It is considered an intermediate stage between normal age-related cognitive decline and more serious conditions like dementia. Individuals with mild cognitive impairment may experience forgetfulness, difficulty concentrating, and challenges in decision-making. However, these changes do not significantly interfere with daily life and activities. The condition may remain stable, improve, or progress to more severe cognitive disorders. The progression of mild cognitive impairment varies among individuals.
Sweden 
